Definitions and notes about data elements available in the National Prescription Drug Utilization Information System secure online analytical environment.
Joint report released by Accreditation Canada, the Canadian Institute for Health Information, the Canadian Patient Safety Institute and the Institute for Safe Medication Practices Canada, aimed at reducing medication-related errors as a priority for advancing safe, quality health care in Canada.
A self-directed user guide for the National Prescription Drug Utilization Information System reporting system that covers basic steps of accessing and manipulating data.
A document providing definitions, rationale and mapping for the dosage form descriptions used in the National Prescription Drug Utilization Information System.
Overview of drug spending, impact of cost drivers, changes in drug discovery and pharmaceutical policy that influence the availability, use and price of drugs.
Examines the privacy, confidentiality and security risks associated with the NPDUIS Database.
Report on the use of three psychotropic drug classes among seniors: antidepressants, benzodiazepines and antipsychotics.
Information sheet highlighting public drug program spending on seniors, including the number and types of drugs used, with a focused analysis on potentially inappropriate drug use.
Drug claims data and comparative drug coverage information can be accessed through this reporting application
Report on public drug program spending on seniors, including the number and types of drugs used.